Health-care companies were flat as some brokerages turned bullish on the sector.
UnitedHealth Group and other managed-care health insurers rose after analysts at brokerage Deutsche Bank said the "muddled' Democratic race for a presidential nominee had diminished the chances that a candidate with a radical health-care reform plan will take the White House.
Clinical trials conducted in Wuhan to test Gilead Sciences' antiviral drug -- a promising remedy for the new coronavirus -- are going more slowly than hoped for as the drugmaker struggles to recruit qualified patients, underscoring the challenges in quickly developing drugs during outbreaks. After 10 days, Gilead has recruited fewer than 200 of the 700 people it's seeking for the trial, as most sufferers had already started taking other medications, disqualifying themselves.
Write to Rob Curran at firstname.lastname@example.org